Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pappolla

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Neurobiology of Disease|October 11, 2001
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's diseaseL M Refolo, M A Pappolla, J LaFrancois, et al.
Biochemistry|December 6, 2001
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptideB Poeggeler, L Miravalle, M G Zagorski, et al.
Neurology|July 23, 2003
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyM A Pappolla, T K Bryant-Thomas, D Herbert, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Neurobiology of Disease|October 11, 2001
A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's diseaseL M Refolo, M A Pappolla, J LaFrancois, et al.
Biochemistry|December 6, 2001
Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptideB Poeggeler, L Miravalle, M G Zagorski, et al.
Neurology|July 23, 2003
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathologyM A Pappolla, T K Bryant-Thomas, D Herbert, et al.
Pageof 6